Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MICHAEL FRUMOVITZ and PAMELA THERESE SOLIMAN.
MICHAEL FRUMOVITZ
Connection Strength
4.750
PAMELA THERESE SOLIMAN
  1. Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships. Obstet Gynecol. 2012 Mar; 119(3):504-8.
    View in: PubMed
    Score: 0.414
  2. Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study. Gynecol Oncol. 2024 Oct 12; 191:143-149.
    View in: PubMed
    Score: 0.248
  3. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers. Curr Oncol Rep. 2022 11; 24(11):1521-1529.
    View in: PubMed
    Score: 0.212
  4. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357.
    View in: PubMed
    Score: 0.178
  5. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
    View in: PubMed
    Score: 0.172
  6. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol. 2018 Sep; 29(5):e68.
    View in: PubMed
    Score: 0.159
  7. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.
    View in: PubMed
    Score: 0.149
  8. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
    View in: PubMed
    Score: 0.146
  9. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol. 2016 08; 142(2):283-5.
    View in: PubMed
    Score: 0.139
  10. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44.
    View in: PubMed
    Score: 0.133
  11. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
    View in: PubMed
    Score: 0.125
  12. Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. Gynecol Oncol Rep. 2014 Dec; 10:28-9.
    View in: PubMed
    Score: 0.124
  13. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol. 2014 Dec; 135(3):451-4.
    View in: PubMed
    Score: 0.124
  14. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep; 134(3):546-51.
    View in: PubMed
    Score: 0.122
  15. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.
    View in: PubMed
    Score: 0.117
  16. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014 Jan; 132(1):114-8.
    View in: PubMed
    Score: 0.117
  17. Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecol Oncol. 2013 Dec; 131(3):730-3.
    View in: PubMed
    Score: 0.115
  18. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013 Apr; 20(4):1355-9.
    View in: PubMed
    Score: 0.108
  19. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
    View in: PubMed
    Score: 0.107
  20. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol. 2012 May; 125(2):336-42.
    View in: PubMed
    Score: 0.103
  21. Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: an analysis of surgical outcomes. Gynecol Oncol. 2012 Apr; 125(1):252-5.
    View in: PubMed
    Score: 0.102
  22. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
    View in: PubMed
    Score: 0.100
  23. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.
    View in: PubMed
    Score: 0.095
  24. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4.
    View in: PubMed
    Score: 0.093
  25. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.
    View in: PubMed
    Score: 0.082
  26. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol. 2008 Nov; 111(2):197-201.
    View in: PubMed
    Score: 0.082
  27. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S25-8.
    View in: PubMed
    Score: 0.080
  28. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S21-4.
    View in: PubMed
    Score: 0.080
  29. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy. 2024 Jan-Feb; 23(1):1-9.
    View in: PubMed
    Score: 0.058
  30. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.
    View in: PubMed
    Score: 0.050
  31. An Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage. 2021 06; 61(6):1305-1310.
    View in: PubMed
    Score: 0.048
  32. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097.
    View in: PubMed
    Score: 0.044
  33. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102.
    View in: PubMed
    Score: 0.041
  34. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol. 2018 11; 151(2):374-380.
    View in: PubMed
    Score: 0.041
  35. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
    View in: PubMed
    Score: 0.037
  36. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol. 2016 Feb 01; 23(2):186-93.
    View in: PubMed
    Score: 0.033
  37. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
    View in: PubMed
    Score: 0.033
  38. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53.
    View in: PubMed
    Score: 0.031
  39. Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes? Gynecol Oncol. 2014 Aug; 134(2):248-52.
    View in: PubMed
    Score: 0.030
  40. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):366-71.
    View in: PubMed
    Score: 0.029
  41. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013 Jun; 129(3):580-5.
    View in: PubMed
    Score: 0.028
  42. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8.
    View in: PubMed
    Score: 0.027
  43. Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31.
    View in: PubMed
    Score: 0.026
  44. Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Jun; 125(3):556-60.
    View in: PubMed
    Score: 0.026
  45. Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynecol Oncol. 2012 May; 125(2):326-9.
    View in: PubMed
    Score: 0.026
  46. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.
    View in: PubMed
    Score: 0.026
  47. Comparison of single-port laparoscopy, standard laparoscopy, and robotic surgery in patients with endometrial cancer. Ann Surg Oncol. 2012 May; 19(5):1583-8.
    View in: PubMed
    Score: 0.025
  48. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
    View in: PubMed
    Score: 0.025
  49. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol. 2012 Feb; 124(2):276-80.
    View in: PubMed
    Score: 0.025
  50. Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer. 2011 Jul; 21(5):936-40.
    View in: PubMed
    Score: 0.025
  51. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34.
    View in: PubMed
    Score: 0.024
  52. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol. 2010 Oct; 116(4):956-961.
    View in: PubMed
    Score: 0.023
  53. Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol. 2011 Jan; 120(1):47-51.
    View in: PubMed
    Score: 0.023
  54. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5.
    View in: PubMed
    Score: 0.023
  55. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
    View in: PubMed
    Score: 0.022
  56. Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol. 2009 Mar; 112(3):501-5.
    View in: PubMed
    Score: 0.021
  57. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
    View in: PubMed
    Score: 0.020
  58. Are women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct; 103(1):151-4.
    View in: PubMed
    Score: 0.017
  59. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.